Retinal Vein Occlusion

Size: px
Start display at page:

Download "Retinal Vein Occlusion"

Transcription

1 Retinal Update 2018 Retinal Vein Occlusion Case Presentations to Myself

2 Branch Vein Occlusion What medical evaluation do you recommend for this 72 year old patient? Is there anything you ask of your medical consultant if this patient is 36 years old?

3 Branch Vein Occlusion Do you initiate Would a medical you treat evaluation this patient? in a 65 yo woman? 20/20 When do you see this patient in follow-up?

4 Branch Vein Occlusion Is this a twig vein occlusion or simply hypertensive retinopathy?

5 Branch Vein Occlusion Would you treat this patient with a twig vein occlusion and CME? 20/40 Does the vision influence what drug you use? If there is 20/20 vision, but CME, do you treat?

6 Branch Vein Occlusion What is your initial management of this patient? 20/80 Do you inject anti-vegf on a fixed schedule, PRN or or treat and extend?

7 Branch Vein Occlusion This pt has had 8 Lucentis injections Do you switch therapies? If you switch, to what therapy do you switch?

8 Branch Vein Occlusion Do you use Is combination it possible to therapy treat with for laser? an acute BVO? 20/50 How long What will it combinations take for the hemorrhage do you use? to resolve, What is the role so that of steroid laser could in the be treatment used? of BVO?

9 Branch Vein Occlusion Do you treat a patient who presents with a chronic BVO differently? 20/200 What is your initial management of this eye?

10 Branch Vein Occlusion 6860 y/o year pt with old man no CME followed followed without without treatment treatment for one for year 1 year Do you start treatment now or do you continue to follow? 20/20 How do you treat this patient?

11 Branch Vein Occlusion Do This you eye perform has received an OCT five on injections every follow-up of Avastin visit? 20/63 20/63 The exudate seems to have increased Is she getting worse?

12 Branch Vein Occlusion How do you treat and follow this patient with ischemic BVO? Do you hold off on PRP until there is VH or NVE? Do you ever treat ischemic retina with PRP in order to decrease the VEGF load prior to initiating injections?

13 Branch Vein Occlusion If you don t treat ischemia with PRP, what is your follow-up plan? Why does the inferotemporal quadrant have a different color?

14 What is subthreshold micropulse laser and does it have a role in the treatment of vein occlusion? Branch Vein Occlusion Do you treat near the fovea with laser?

15 Branch Vein Occlusion Does OCT-A have a roll in the management of BVO? Superficial Capillary Plexus Deep Capillary Plexus

16 BRVO/Quadrantic CRVO Is this a BVO or a quadrantic CRVO? Does it matter in terms of treatment? Do you consider the multiple CWS a poor prognostic sign for final visual acuity?

17 Central Retinal Vein Occlusion 78 yr old female with 20/20 vision Do you initiate any medial evaluation?

18 Central Retinal Vein Occlusion 39 yr old patient Do you initiate a search for clotting disorders? 20/20 Do you treat a CRVO with 20/20 vision?

19 Central Retinal Vein Occlusion What is your initial management in this 78 yo man? 20/100

20 Central Retinal Vein Occlusion Do you obtain an angiogram before initiating treatment? If a patient has an ischemic CRVO but no CME, do you treat?

21 Central Retinal Vein Occlusion Do you inject anti-vegf on a fixed schedule, PRN or Treat and Extend protocol? Do you treat until the macula is dry before extending the next injection?

22 Hemi Central Retinal Vein Occlusion Is the treatment of a hemi-crvo the same? Is the visual prognosis better?

23 Central Retinal Vein Occlusion If you treat and extend, and the patient comes back with recurrent CME after 8 weeks, do you inject and bring them back in 4 weeks? 6 weeks?

24 Central Retinal Vein Occlusion How long do you continue your initial treatment before you consider switching to another therapy? To what therapy do you switch?

25 Central Retinal Vein Occlusion Do you ever use combination therapy with CRVO? What combination do you use? 20/160 Do you use steroids in the management of CRVO?

26 Central Retinal Vein Occlusion If this patient has had filtering surgery and is pseudophakic, are you more willing to use Ozurdex? Do you treat the patient first with Triescence or PST Kenolog?

27 VEGF Levels in Ischemia Lucentis shown to be superior to Avastin in its affinity and ability to bind VEGF-A CRVO are usually more ischemic than BVO What is the role of Avastin in the treatment of CRVO?

28 Central Retinal Vein Occlusion Have you been able to reduce the treatment burden by using Eylea? If Eylea injections are required every month, how long before you switch to something else?

29 Central Retinal Vein Occlusion Do you perform a fluorescein angiogram prior to stopping anti-vegf treatment? Have you ever found a surprising amount of ischemia? If you find ischemia, how do you treat?

30 Central Retinal Vein Occlusion This patient has had total resolution of her CME Why isn t the vision better? 20/200 20/100 Was there simply more ischemia than we had thought?

31 Central Retinal Vein Occlusion and Rubeosis What is your management? CF

32 Central Retinal Vein Occlusion and Rubeosis If an eye with rubeosis undergoes PRP, and has CME, how do you treat?

33 Bilateral Hemi-CRVO If a patient has bilateral central vein occlusion, do you initiate additional testing? What is the differential diagnosis of a bilateral CRVO?

34 Vitreomacular Traction and ERM following CRVO 20/100 Would you consider surgery or attempt medical treatment first?

35 CRVO and Cilioretinal Artery Occlusion What is the pathophysiology of this condition? What is the management of this patient?

36 Mild CRVO with Perivenular Whitening Inner retinal hyper-reflectivity, intraretinal and subretinal fluid 8/200 Why does such a mild CRVO cause such visual loss? 20/20 What is the prognosis?

37 CRVO with AV Malformation What causes the CRVO?

38 Retinal Update 2018 Retinal Vein Occlusion Case Presentations to Myself

39 Ocular Ischemic Syndrome presenting as CRVO 75 yo man with 80% occlusion of carotid artery How often does OIS present as a CRVO? Does carotid doppler study have a role in CRVO management?

40 Central Retinal Vein Occlusion

41 Central Retinal Vein Occlusion 20/20

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO) Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England (Royal Victoria Infirmary, Sunderland Eye Infirmary, James Cook University Hospital, Darlington Memorial Hospital, University Hospital

More information

Venous Occlusive Diseases

Venous Occlusive Diseases Venous Occlusive Diseases Bruce R. Saran, MD Adjunct Assistant Clinical Professor of Medicine Scheie Eye Institute University of Pennsylvania School of Medicine Philadelphia, PA -a division of: RVO Demographics

More information

Vascular Disease Ocular Manifestations of Systemic Hypertension

Vascular Disease Ocular Manifestations of Systemic Hypertension Vascular Disease Ocular Manifestations of Systemic Hypertension Maynard L. Pohl, OD, FAAO Pacific Cataract & Laser Institute 10500 NE 8 th Street, Suite 1650 Bellevue, WA 98004 USA 425-462-7664 Cerebrovascular

More information

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

ZEISS AngioPlex OCT Angiography. Clinical Case Reports Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy

More information

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital Clinical Case Presentation on Branch Retinal Vein Occlusion Sarita M. Registered Nurse Whangarei Base Hospital Introduction Case Study Pathogenesis Clinical Features Investigations Treatment Follow-up

More information

Past ocular history. DME Case 1. Patient presents blurred VA. Hemoglobin A1c 11.5% -- patient states sugars have not been in good control

Past ocular history. DME Case 1. Patient presents blurred VA. Hemoglobin A1c 11.5% -- patient states sugars have not been in good control Past ocular history Patient presents blurred VA DME Case 1 Hemoglobin A1c 11.5% -- patient states sugars have not been in good control PDR with macular edema OU Rishi Singh MD Cleveland Clinic OD OS 1

More information

Chris Brown, M.D. Eye Specialty Group, PLC Continuing Education Series

Chris Brown, M.D. Eye Specialty Group, PLC Continuing Education Series Chris Brown, M.D. Eye Specialty Group, PLC 2018 Continuing Education Series Disclaimer I have no financial interests in this lecture or any information discussed therein Objectives Fluorescein Angiogram

More information

Diabetic Retinopatathy

Diabetic Retinopatathy Diabetic Retinopatathy Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Arctic DX Macula Risk Advanced

More information

Diabetic maculopathy 11/ An update on. Miss Vasuki Sivagnanavel

Diabetic maculopathy 11/ An update on. Miss Vasuki Sivagnanavel Miss Vasuki Sivagnanavel Consultant Ophthalmologist An update on Diabetic maculopathy Despite advances in the management of diabetes, diabetic retinopathy is already the commonest cause of blindness among

More information

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION MOESTIDJAB DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE AIRLANGGA UNIVERSITY DR SOETOMO HOSPITAL SURABAYA INTRODUCTION

More information

The Era of anti- - - VEGF Kirk L. Halvorson, OD

The Era of anti- - - VEGF Kirk L. Halvorson, OD The Era of anti- - - VEGF Kirk L. Halvorson, OD Introduction: Anti- - - Vascular Endothelial Growth Factor (Anti- - - VEGF) medication is a relatively a new line of medications used in treating a variety

More information

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing

More information

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features

More information

Diabetic Retinopathy

Diabetic Retinopathy Diabetic Retinopathy Diabetes mellitus is one of the leading causes of irreversible blindness worldwide. In the United States, it is the most common cause of blindness in people younger than 65 years.

More information

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Ayman M Khattab MD, FRCS Professor of Ophthalmology Cairo University Diabetic Macular Edema (DME) Diabetic macular

More information

When to Refer to RETINA. Joseph M. Coney, MD February 17, 2017 Memphis, TN

When to Refer to RETINA. Joseph M. Coney, MD February 17, 2017 Memphis, TN When to Refer to RETINA Joseph M. Coney, MD February 17, 2017 Memphis, TN Financial Disclosure Commercial Interest What was received For what role Aerpio Grant Support Contracted Research Alcon Laboratories

More information

Diabetic Retinopathy

Diabetic Retinopathy Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.

More information

Macular edema (ME) is the most common

Macular edema (ME) is the most common MANAGEMENT OF RETINAL VEIN OCCLUSIONS * Peter A. Campochiaro, MD ABSTRACT Macular edema (ME) is the most common cause of reduced vision in patients with retinal vein occlusions (RVOs). The primary cause

More information

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina Diabetic Retinopathy: Managing the Extremes J. Michael Jumper, MD West Coast Retina Case 1: EC 65 y.o. HM No vision complaints Meds: Glyburide Metformin Pioglitazone Va: 20/20 OU 20/20 Case 2: HS 68 y.o.

More information

FA Conference. Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences

FA Conference. Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences FA Conference Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences Patient Presentation CC: (sent by optometrist) Blurry/foggy vision HPI: 62 yo

More information

measure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control

More information

Clinically Significant Macular Edema (CSME)

Clinically Significant Macular Edema (CSME) Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2

More information

Treatment of Retinal Vein Occlusion (RVO)

Treatment of Retinal Vein Occlusion (RVO) Manchester Royal Eye Hospital Medical Retina Services Information for Patients Treatment of Retinal Vein Occlusion (RVO) What is a Retinal Vein Occlusion (RVO)? The retina is the light sensitive layer

More information

An Update on Branch Retinal Vein Occlusion Treatment Studies. Amiee Ho, O.D. Pacific University College of Optometry

An Update on Branch Retinal Vein Occlusion Treatment Studies. Amiee Ho, O.D. Pacific University College of Optometry An Update on Branch Retinal Vein Occlusion Treatment Studies Amiee Ho, O.D. Pacific University College of Optometry Course Description This course focuses on current treatment options available for macular

More information

The Human Eye. Cornea Iris. Pupil. Lens. Retina

The Human Eye. Cornea Iris. Pupil. Lens. Retina The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in

More information

OCT Angiography in Primary Eye Care

OCT Angiography in Primary Eye Care OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central

More information

EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD

EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina Retinal Arcades Macula Optic

More information

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl

More information

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY Diwakar chaudhary *1, 2, Hu shuqiong, Long Yuan and Xiong kun 1 Yangtze University, 1 Nanhuan Road

More information

FROM OUTDATED TO UPDATED Eminence-Based Medicine

FROM OUTDATED TO UPDATED Eminence-Based Medicine FROM OUTDATED TO UPDATED Eminence-Based Medicine Evidence-Based Medicine A REVIEW OF KEY CLINICAL TRIALS Anthony DeWilde, OD FAAO 1 EMINENCE BASED MEDICINE 2 EVIDENCE BASED MEDICINE 3 4 CLINICAL TRIALS

More information

Diabetic Retinopathy Update 2017

Diabetic Retinopathy Update 2017 Diabetic Retinopathy Update 2017 Basis for DR management standards for past 40 years Diabetic Retinopathy Study (DRS) 1971-1989 and Early Treatment of Diabetic Retinopathy Study (ETDRS) 1979-1990 Sundeep

More information

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features

More information

RVO RETINAL VEIN OCCLUSION

RVO RETINAL VEIN OCCLUSION RVO RETINAL VEIN OCCLUSION A guide to understanding RVO Take some time to learn about RVO - it may help you hold on to your vision Retinal vein occlusion is a common disorder of the retina and a leading

More information

Brampton Hurontario Street Brampton, ON L6Y 0P6

Brampton Hurontario Street Brampton, ON L6Y 0P6 Diabetic Retinopathy What is Diabetic Retinopathy Diabetic retinopathy is one of the leading causes of blindness world-wide. Diabetes damages blood vessels in many organs of the body including the eyes.

More information

1/25/2018. Case Management Strategies in Diabetic Retinopathy. Case Study #1: Severe DME. DDOS: 3/31/2016 Va 20/400. Disclosures

1/25/2018. Case Management Strategies in Diabetic Retinopathy. Case Study #1: Severe DME. DDOS: 3/31/2016 Va 20/400. Disclosures Case Management Strategies in Diabetic Retinopathy Disclosures No financial conflict of interest Will discuss off label use of intraocular Bevacizumab (Avastin) for Diabetic Retinopathy Sundeep Dev, MD

More information

4/27/2010 INTRODUCTION TO RETINAL VASCULAR DISEASE VENOUS/VENULAR CENTRAL RETINAL VEIN OBSTRUCTION / CRVO ADDITIONAL FEATURES /COMPLICATIONS

4/27/2010 INTRODUCTION TO RETINAL VASCULAR DISEASE VENOUS/VENULAR CENTRAL RETINAL VEIN OBSTRUCTION / CRVO ADDITIONAL FEATURES /COMPLICATIONS INTRODUCTION TO RETINAL VASCULAR DISEASE VENOUS/VENULAR Leo Semes, OD Professor, UAB Optometry 2 CENTRAL RETINAL VEIN OBSTRUCTION CENTRAL RETINAL VEIN OBSTRUCTION / OCCLUSION (CRVO) obstruction of the

More information

New Developments in the treatment of Diabetic Retinopathy

New Developments in the treatment of Diabetic Retinopathy New Developments in the treatment of Diabetic Retinopathy B. Jeroen Klevering University Medical Centre Nijmegen - The Netherlands Topics Management of diabetic retinopathy Interventions a. primary (prevention)

More information

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist Serious Eye diseases, New treatments Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist 5 major causes of loss of vision Cataracts Glaucoma Macular degeneration Retinal Vein occlusions

More information

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic 25.6 million adults 11.3% of the adult population 10.9 million adults 65 years and older 26.9% of this age population 79 million people are Pre-diabetic!!

More information

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection Kenalog/SS/ST/04.2012/v1.1 review 05.2013 Page 1 Introduction Your doctor has found that you have leakage of

More information

Diabetic Retinopathy A Presentation for the Public

Diabetic Retinopathy A Presentation for the Public Diabetic Retinopathy A Presentation for the Public Ray M. Balyeat, MD The Eye Institute Tulsa, Oklahoma The Healthy Eye Light rays enter the eye through the cornea, pupil and lens. These light rays are

More information

A Patient s Guide to Diabetic Retinopathy

A Patient s Guide to Diabetic Retinopathy Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes

More information

OCT Angiography The Next Frontier

OCT Angiography The Next Frontier Choroid Retina avascular 5/13/2017 OCT Angiography The Next Frontier Pierce Kenworthy OD, FAAO June 9, 2017 OCT Angiography (OCTA) 2016 Non-invasive, motion contrast imaging Represents erythrocyte movement

More information

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012 Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012 Proliferative Diabetic Retinopathy Laser Treatments Medical Treatment Surgical Treatment Diabetic Macular Edema Laser

More information

The Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR

The Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR The Diabetic Retinopathy Clinical Research Network Management of DME in Eyes with PDR 1 What Has Been Learned? Diabetic Retinopathy Treatment Protocol F: Results suggest that clinically meaningful differences

More information

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Recalcitrant Diabetic Macular Oedema: Therapeutic Options December 2007 A. Giridhar et al. - Recalcitrant DME 451 CONSULTATION S E C T I O N Recalcitrant Diabetic Macular Oedema: Therapeutic Options Dr. Cyrus M Shroff 1, Dr. N S Muralidhar 2, Dr. R Narayanan

More information

Goals/Objectives. Disclosures. Risk Factors RAO and RVO. Risk Factors. Retinal Artery Occlusions Branch and Central

Goals/Objectives. Disclosures. Risk Factors RAO and RVO. Risk Factors. Retinal Artery Occlusions Branch and Central Jeffrey D. Perotti, OD, MS Indiana University School of Optometry Goals/Objectives RETINAL VASCULAR OCCLUSIONS FOR THE PRIMARY CARE CLINICIAN Using cases as a framework, review current evaluation and management

More information

OCT Assessment of the Vitreoretinal Relationship in CSME

OCT Assessment of the Vitreoretinal Relationship in CSME December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction

More information

FRANZCO, MD, MBBS. Royal Darwin Hospital

FRANZCO, MD, MBBS. Royal Darwin Hospital Diabetes and Eye By Dr. Nishantha Wijesinghe FRANZCO, MD, MBBS Consultant Ophthalmologist Royal Darwin Hospital 98% of Diabetics do not need to suffer from severe visual loss Yet Diabetic eye disease is

More information

Diabetic Macular Edema Treatment in the 21st Century

Diabetic Macular Edema Treatment in the 21st Century Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

OCT Interpretation in Retinal Disease

OCT Interpretation in Retinal Disease OCT Interpretation in Retinal Disease Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Advanced Ocular

More information

The Foundation WHAT IS THE RETINA?

The Foundation WHAT IS THE RETINA? The Foundation American Society of Retina Specialists Committed to improving the quality of life of all people with retinal disease. Branch Retinal Vein Occlusion Retinal vein occlusions occur when there

More information

Case Follow Up. Sepi Jooniani PGY-1

Case Follow Up. Sepi Jooniani PGY-1 Case Follow Up Sepi Jooniani PGY-1 Triage 54 year old M Pt presents to prelim states noticed today he had reddness to eyes, states worse in R eye. Pt denies any pain or itching. No further complaints.

More information

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Retina Conference Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Subjective CC/HPI: 64 year old Caucasian female referred by outside ophthalmologist

More information

Ophthalmology Macular Pathways

Ophthalmology Macular Pathways Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological

More information

Paradigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor

Paradigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor Paradigm Shift in the treatment of Diabetic Retinopathy Haytham I. S. Salti, MD Associate Professor Disclosure No financial interests related to the subject matter of this talk This presentation includes

More information

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington I Jay M. Haynie, OD, FAAO have received honoraria from the following companies: Reichert Technologies Notal Vision Carl Zeiss Meditec

More information

NO FINANCIAL INTERESTS ARE DISCLOSED BY THE AUTHORS

NO FINANCIAL INTERESTS ARE DISCLOSED BY THE AUTHORS OCULAR FINDINGS IN APLASTIC ANEMIA: MULTICENTER STUDY & LITERATURE REVIEW Ahmad M Mansour1, MD, Jong Wook Lee, MD, PhD, Seung Ah Yahng, MD, Kyu Seop Kim, MD, Maha Shahin, MD, Nelson Hamerschlak, MD, PhD,

More information

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy Fawwaz Al Mamoori* Medical Retina Department, Eye Specialty Hospital,

More information

Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series

Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Joseph J. Pizzimenti, OD, FAAO Associate Professor Nova Southeastern University The Eye Care Institute pizzimen@nova.edu

More information

Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion

Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Man-Seong Seo,* Jae-Moon Woo* and Jeong-Jin Seo *Department of Ophthalmology, Chonnam

More information

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to

More information

OCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014

OCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014 OCT Interpretation Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Olympia Tacoma Renton Kennewick - Washington Carl Zeiss

More information

Themes for conferences No 42

Themes for conferences No 42 Themes for conferences No 42 Systemic Arterial Hypertension Venous Occlusive Disease Arterial Occlusive Disease Ocular Ischemic Syndrome Med. pract. Anton R. Xavier Dr. med. Claudia Zawinka Dr. med. Stephan

More information

PART 1: GENERAL RETINAL ANATOMY

PART 1: GENERAL RETINAL ANATOMY PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is

More information

Facts About Diabetic Eye Disease

Facts About Diabetic Eye Disease Facts About Diabetic Eye Disease Points to Remember 1. Diabetic eye disease comprises a group of eye conditions that affect people with diabetes. These conditions include diabetic retinopathy, diabetic

More information

EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion

EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion George Bresnick MD MPA Jorge Cuadros OD PhD Anatomy of the eye: 3 Normal Retina

More information

RETINAL VEIN OCCLUSIONS (RVO) PREFERRED PRACTICE PATTERNS (PPP) Philippines: 2016

RETINAL VEIN OCCLUSIONS (RVO) PREFERRED PRACTICE PATTERNS (PPP) Philippines: 2016 RETINAL VEIN OCCLUSIONS (RVO) PREFERRED PRACTICE PATTERNS (PPP) Philippines: 2016 The Retinal Vein Occlusions (RVO) Preferred Practice Patterns (PPP) Philippines: 2016 was prepared by the VitreoRetina

More information

The use of a high-intensity laser to create an anastomotic

The use of a high-intensity laser to create an anastomotic Case Report 866 Laser Chorioretinal Venous Anastomosis for Progressive Nonischemic Central Retinal Vein Occlusion Chih-Hsin Chen, MD; Chien-Hsiung Lai 1, MD; Hsi-Kung Kuo, MD The use of high or medium-intensity

More information

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May BRAND NAME Lucentis GENERIC NAME ranibizumab MANUFACTURER Genentech, Inc. DATE OF APPROVAL June 30, 2006 PRODUCT LAUNCH DATE July 13, 2006 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review of

More information

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN) Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

More information

Research Article Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

Research Article Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion Hindawi Publishing Corporation Journal of Ophthalmology Volume 2016, Article ID 9875741, 6 pages http://dx.doi.org/10.1155/2016/9875741 Research Article Differentiation between Good and Low-Responders

More information

Leo Semes, OD, FAAO UAB Optometry

Leo Semes, OD, FAAO UAB Optometry Leo Semes, OD, FAAO UAB Optometry Safe; inert Has long track record - over 45 years Mixes with plasma and highlights blood vessel compromise Using specific exciting (490 nm)and absorption (510 nm) filters

More information

Outline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado

Outline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado Outline Preventing & Treating Diabetes Related Blindness Justin Kanoff, MD Eye Care Center of Northern Colorado 303 974 4302 Introduction to Eye Care Center of Northern Colorado How the eye works Eye problems

More information

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Diabetic Retinopathy Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012 Outline Statistics Anatomy Categories Assessment Management Risk factors What do you need to do? Objectives Summarize the

More information

EU Regulatory workshop Ophthalmology clinical development and scientific advice. Industry view on DME and macular edema secondary to RVO

EU Regulatory workshop Ophthalmology clinical development and scientific advice. Industry view on DME and macular edema secondary to RVO EU Regulatory workshop Ophthalmology clinical development and scientific advice. Industry view on DME and macular edema secondary to RVO Yehia Hashad, M.D. Vice President and Global Therapeutic Area Head

More information

Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion

Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 648-652 Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion J. SWART 1,2, J.W. REICHERT-THOEN 1, M.S.

More information

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015 So What Parts of the Eye Retina are Affected by VHL Neural tissue

More information

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 1. This course is designed to review the important ophthalmic literature that was released between October 2013

More information

Drug Discoveries & Therapeutics. 2016; 10(3): An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion

Drug Discoveries & Therapeutics. 2016; 10(3): An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion Brief Report Drug Discoveries & Therapeutics. 2016; 10(3):167-171. 167 DOI: 10.5582/ddt.2016.01037 An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion Robert D Steigerwalt

More information

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES

11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES MACULAR MALADIES: TYPICAL & ATYPICAL CASES Dawn Pewitt, OD, FAAO Triad Eye Institute, Grove, OK Dpewitt@triadeye.com Disclosure Statement: No financial disclosures COPE 51218-PS Please silence all mobile

More information

Applying New Data to Improve the Standard of Care in Retinal Disease. With articles by Gaurav K. Shah, MD Carl D. Regillo, MD.

Applying New Data to Improve the Standard of Care in Retinal Disease. With articles by Gaurav K. Shah, MD Carl D. Regillo, MD. Supplement to July/August 2012 CME Activity Applying New Data to Improve the Standard of Care in Retinal Disease With articles by Gaurav K. Shah, MD Carl D. Regillo, MD Release date: August 2012. Expiration

More information

Research Article http://www.alliedacademies.org/clinical-ophthalmology-and-vision-science/ A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal

More information

Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus

Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus Original Paper Received: December 9, 2014 Accepted: February 25, 2015 Published online: June 12, 2015 Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus Alan R. Berger a Alan F. Cruess

More information

Central venous occlusion

Central venous occlusion Central venous occlusion Central venous occlusion (right eye) There are dark haemorrhages at the macula and all over the retina. Choroidal haemangioma A choroidal haemangioma has salmon pink colour. There

More information

Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy

Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy Case Reports in Ophthalmological Medicine Volume 2015, Article ID 813414, 4 pages http://dx.doi.org/10.1155/2015/813414 Case Report Increase in Central Retinal Edema after Subthreshold Diode Micropulse

More information

Posterior Segment Macular Edema

Posterior Segment Macular Edema Posterior Segment Macular Edema Treatment of Macular Edema following Branch Retinal Vein Occlusion Raafay Sophie, MD 1 and Peter A Campochiaro, MD 2 1. Post-doctoral Fellow; 2. Eccles Professor of Ophthalmology

More information

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS ORIGINAL ARTICLE ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS Aggarwal Somesh VP 1, Shah Sonali N 2, Bharwada Rekha M 3,

More information

INTRAVITREOUS BEVACIZUMAB IN THE TREATMENT OF MACUAR EDEMA FROM BRANCH RETINAL VEIN OCCLUSION AND HEMISPHERE RETINAL VEIN OCCLUSION (AN AOS THESIS)

INTRAVITREOUS BEVACIZUMAB IN THE TREATMENT OF MACUAR EDEMA FROM BRANCH RETINAL VEIN OCCLUSION AND HEMISPHERE RETINAL VEIN OCCLUSION (AN AOS THESIS) INTRAVITREOUS BEVACIZUMAB IN THE TREATMENT OF MACUAR EDEMA FROM BRANCH RETINAL VEIN OCCLUSION AND HEMISPHERE RETINAL VEIN OCCLUSION (AN AOS THESIS) BY Gary Edd Fish MD ABSTRACT Purpose: To compare intravitreous

More information

Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham. bars 2014

Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham. bars 2014 Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham bars 2014 Declaration of interest I have sat on Advisory boards for Novartis and Bayer Involved in Novartis sponsored

More information

Neuropathy (NAION) and Avastin. Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013

Neuropathy (NAION) and Avastin. Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013 Non Arteritic Ischemic Optic Neuropathy (NAION) and Avastin Shalom Kelman, MD Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013 Anterior Ischemic Optic Neuropathy Acute, painless, visual loss,

More information

IRIDEX IQ 577 TM Does What Other Lasers Can t. Ahad Mahootchi, MD The Eye Clinic of Florida

IRIDEX IQ 577 TM Does What Other Lasers Can t. Ahad Mahootchi, MD The Eye Clinic of Florida IRIDEX IQ 577 TM Does What Other Lasers Can t Ahad Mahootchi, MD The Eye Clinic of Florida IRIDEX IQ 577 One Machine That Treats More Patients More Diseases IRIDEX IQ 577 Safely treats the macula without

More information

Photocoagulation of disciform macular lesions

Photocoagulation of disciform macular lesions British Journal of Ophthalmology, 1979, 63, 669-673 Photocoagulation of disciform macular lesions with krypton laser A. C. BIRD AND R. H. B. GREY From the Institute of Ophthalmology, Moorfields Eye Hospital,

More information

Interesting, unusual, eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN

Interesting, unusual, eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN 56 yo female, EW Presented to outside Ophthalmologist Diagnosed with viral conjunctivitis, but viral testing was negative. Also had pain around the eye and on the right side of her face Interesting, unusual,

More information

There are no published randomized, double-blind trials comparing aflibercept to other therapies in neovascular AMD.

There are no published randomized, double-blind trials comparing aflibercept to other therapies in neovascular AMD. Subject: Eylea (aflibercept) Original Effective Date: 7/11/2014 Policy Number: MCP-191 Revision Date(s): 10/11/2016 Review Date(s): 12/16/2015; 10/11/2016, 6/22/2017, 7/10/2018 DISCLAIMER This Medical

More information

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome Hindawi Publishing Corporation Journal of Ophthalmology Volume 215, Article ID 62372, 5 pages http://dx.doi.org/1.1155/215/62372 Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic

More information

Anti VEGF Agents in Retinal Disorders Current Scenario

Anti VEGF Agents in Retinal Disorders Current Scenario Retina Anti VEGF Agents in Retinal Disorders Current Scenario Charu Gupta MS Charu Gupta MS, Cyrus M. Shroff MD Shroff Eye Centre, New Delhi T is a group of proteins involved in the regulation of angiogenesis,

More information

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Ophthalmic VEGF Inhibitors Page: 1 of 5 Last Review Date: September 20, 2018 Ophthalmic VEGF Inhibitors

More information

Office Based Practice. Vitreoretinal Disease & Surgery. Coding Fiesta Vitreoretinal Disease & Surgery September 23, 2017 ADULT RETINA

Office Based Practice. Vitreoretinal Disease & Surgery. Coding Fiesta Vitreoretinal Disease & Surgery September 23, 2017 ADULT RETINA Vitreoretinal Disease & Surgery Coding Fest 2017 Vitreoretinal Surgery & Disease University of FL College of Medicine ADULT RETINA Medical Retina Surgical Retina Age Related Vascular Disease Vascular Disease

More information

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre 11:00-11:55 WS #115: The Revolution in Macular Degeneration Management 12:05-13:00 WS #127: The Revolution in Macular

More information